ArTiMist Update
Filed with ASX ·
On 6ix: 6ix.com/news/artimist-update
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- SUDA Signs Option To Acquire NovaMist Technology
- Suda Completes Successful $5.6m Capital Raising
- Appendix 4D Half Year Ended 31 December 2013
- Westcoast Expands To East Coast
- Half Yearly Report and Accounts (including Appendix 4D)
Later from Arovella Therapeutics
- 5000 Patient study findings are very positive for artimist
- EMS UPDATE
- Response to ASX Appendix 4C Query
- Update
- Update on Eastland`s subsidiary
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics